In the new stage of accelerating drug research and development towards high quality and compliance, the source controllability of pharmaceutical excipients has become a key factor in the success of formulations. Recently, Nanjing local innovative drug R&D enterprises announced that their multiple injection and oral solid preparation projects have officially adoptedNanjing Chemical Reagent Co., LtdProvided by (hereinafter referred to as "Southern Test")Pharmaceutical grade sodium hydroxide excipientThe product has been registered and successfully published at the National Center for Drug Evaluation (CDE) with registration number:F20200000609 (A), F20230000026 (multi standard).

Sodium hydroxide pharmaceutical excipientAs a commonly used pH regulator, it is used in injection, eye drops, sustained-release tablets and other formulations to precisely control the acidity and alkalinity of the system, directly affecting the stability, solubility and bioavailability of the main drug. Choosing compliant and high-quality sodium hydroxide pharmaceutical excipients can not only effectively reduce quality risks in the drug production process, but also enhance the stability of the drug and the safety of patient medication. Cooperating with Nan Shi not only shortens the response time of the supply chain, but also ensures the traceability of auxiliary material quality throughout the entire process and worry free registration. ”

This cooperation marks a solid step forward in the local ecological synergy of "research and development+raw materials" in Nanjing, and also provides a demonstration model for the independent and controllable development of the regional biopharmaceutical industry chain. This cooperation is not only a reflection of the complementary advantages of both sides, but also a practice of the commitment to high-quality development of the pharmaceutical industry.